News
10h
SurvivorNet on MSNMore Patients May Be Able To Avoid Cancer Surgery; Immunotherapy Drug Jemperli Shows Promise Across Several Different Cancer TypesPatients with certain types of early stage cancer, particularly those affecting the gastrointestinal system, may be able to ...
Anal cancer has been steadily increasing in the United States, with the biggest jumps among older women, especially white and Hispanic women - a shift that challenges assumptions about high-risk ...
Colorectal tumors can vary in molecular mutations among individuals and communities, according to a new study from ...
A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery ...
A new trial has found the addition of immunotherapy treatment alongside extended radiotherapy has led to better rates of remission in patients ...
When Peters first noticed blood on toilet paper after bowel movements at age 33, her doctors quickly dismissed it as a ...
These findings highlight specific patient groups who may benefit from targeted screening for anal HPV and anal cancer,” said lead study author Dr. Ashley Robinson.
Prostate cancer is the most commonly diagnosed cancer in men worldwide, accounting for more than 1.4 million new cases each ...
Prostate cancer is the most commonly diagnosed cancer in men worldwide, accounting for more than 1.4 million new cases each ...
Up to 90% of colorectal cancers can be cured if caught early. Learn about screening options at Fred Hutch to protect your health.
A new clinical trial shows the immunotherapy drug dostarlimab may eliminate the need for surgery and chemotherapy in certain ...
Can ctDNA-guided therapy stop cancer’s return, sparing patients unnecessary treatment? A new study suggests it might.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results